The voluntary recall was sparked by incorrect strength labels, according to the manufacturer.

Summary

Clonazepam, a prescription medication for seizures and anxiety, is being recalled due to mislabeling errors.

The affected products, distributed nationwide, may cause adverse reactions if taken in incorrect doses.

Consumers are advised to discontinue use and contact Inmar, Inc. with questions.